-
Article
Open AccessProspective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases
In pediatric rheumatic diseases (PRD), adalimumab is dosed using fixed weight-based bands irrespective of methotrexate co-treatment, disease activity (DA) or other factors that might influence adalimumab pharm...
-
Article
Open AccessCorrection to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials
-
Article
Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the Juvenile Inflammatory Rheumatism cohort
To determine vaccination coverage among a French cohort of children with recurrent autoinflammatory fever syndromes (RFS).
-
Article
Open AccessBiologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials
Biologic disease modifying antirheumatic drugs (bDMARDs) and Janus Kinase (JAK) inhibitors are prescribed in adult and paediatric rheumatology. Due to age-dependent changes, disease course, and pharmacokinetic...
-
Article
Open AccessProceedings of the 23rd Paediatric Rheumatology European Society Congress: part two
-
Article
Open AccessClinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression
To analyze the clinical presentation and complications of varicella zoster virus (VZV) infection in children with rheumatic diseases treated with immunosuppressive medication such as biological disease-modifyi...
-
Article
Open AccessPrescribed but not approved: biologic agents used without approval in juvenile idiopathic arthritis in Switzerland, France and Belgium
-
Article
Open AccessSwitch of biotherapies in patients with juvenile idiopathic arthritis: analyses of the JIR cohort data
-
Article
Open AccessMulticenter retrospective study of biological tolerance in juvenile idiopathic arthritis (jir-cohort)